InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (6 ops.)
Browse the full record of transactions filed by FORMELA JEAN FRANCOIS. Director active across 3 companies, notably Intellia Therapeutics, Inc.. In total, 11 disclosures have been published. Total volume traded: €145.3m. The latest transaction was filed on 14 June 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations11 total
05,197 shares0
Common Stock
SEC:0001209191-22-037598:0·
€2m125,000 shares@ €13.6477100.0% of flow
Common Stock
SEC:0001209191-21-069645·
Ideal exit: 25 Dec 2021 (T+270)
€2m125,000 shares@ €13.647750.0% of flow
Common Stock
SEC:0001209191-21-069645:0·
Ideal exit: 25 Dec 2021 (T+270)
€66m2,055,063 shares@ €32.1898100.0% of flow
Common Stock
SEC:0001209191-21-056045·
€66m2,055,063 shares@ €32.189850.0% of flow
Common Stock
SEC:0001209191-21-056045:0·
€3m26,019 shares@ €106.48090.15% mcap57.7% of flow
Common Stock
SEC:0001104659-21-086607·
€3m26,019 shares@ €106.48090.15% mcap28.8% of flow
Common Stock
SEC:0001104659-21-086607:0·
02,094 shares0
Common Stock
SEC:0001209191-21-043374·
02,094 shares0
Common Stock
SEC:0001209191-21-043374:0·
€2m29,071 shares@ €69.97710.11% mcap42.3% of flow
Common Stock
SEC:0001104659-21-081255·
€2m29,071 shares@ €69.97710.11% mcap21.2% of flow
Common Stock
SEC:0001104659-21-081255:0·
11 of 11 declarations
About FORMELA JEAN FRANCOIS
FORMELA JEAN FRANCOIS is a director at Intellia Therapeutics, Inc. and also holds insider roles at Translate Bio, Inc. and Ikena Oncology, Inc.
